相似文献
1
Spectrum of pleiotropic effects of statins in heart failure.
Heart Fail Clin. 2008 Apr;4(2):153-61. doi: 10.1016/j.hfc.2008.01.007.
2
Clinical investigations of statins in heart failure: ventricular function and anti-remodeling.
Heart Fail Clin. 2008 Apr;4(2):177-86. doi: 10.1016/j.hfc.2008.01.002.
3
[Should statins be part of the treatment of heart failure?].
Ann Cardiol Angeiol (Paris). 2004 Jul;53(4):209-16. doi: 10.1016/j.ancard.2004.03.002.
4
The emerging role of statins in the treatment of heart failure.
J Am Coll Cardiol. 2006 Jan 17;47(2):342-4. doi: 10.1016/j.jacc.2005.10.031. Epub 2005 Dec 20.
5
Statin therapy in heart failure: prognostic effects and potential mechanisms.
Am Heart J. 2007 Oct;154(4):617-23. doi: 10.1016/j.ahj.2007.05.020.
6
Statins and prevention of atrial fibrillation in patients with heart failure.
Int J Cardiol. 2009 Jul 10;135(3):e83-4. doi: 10.1016/j.ijcard.2008.04.042. Epub 2008 Jul 14.
7
Statins: potential new indications in inflammatory conditions.
Atheroscler Suppl. 2006 Apr;7(1):31-5. doi: 10.1016/j.atherosclerosissup.2006.01.005. Epub 2006 Feb 28.
8
Investigations of statins in heart failure: inflammatory biomarkers and hormones.
Heart Fail Clin. 2008 Apr;4(2):171-6. doi: 10.1016/j.hfc.2008.01.003.
9
Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure.
Cardiology. 2013;124(1):36-7. doi: 10.1159/000345781. Epub 2013 Jan 5.
10
Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Am J Cardiovasc Drugs. 2010;10 Suppl 1:10-7. doi: 10.2165/1158822-S0-000000000-00000.
引用本文的文献
1
The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
Pharmacol Rep. 2021 Feb;73(1):261-268. doi: 10.1007/s43440-020-00135-w. Epub 2020 Jul 21.
2
Residual inflammatory risk after contemporary lipid lowering therapy.
Eur Heart J Qual Care Clin Outcomes. 2020 Apr 1;6(2):105-111. doi: 10.1093/ehjqcco/qcz055.
3
Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes.
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):294S-300S. doi: 10.1177/1076029618808915. Epub 2018 Nov 12.
4
Prognostic Impact of Statin Intensity in Heart Failure Patients With Ischemic Heart Disease: A Report From the CHART-2 (Chronic Heart Failure Registry and Analysis in the Tohoku District 2) Study.
J Am Heart Assoc. 2018 Mar 14;7(6):e007524. doi: 10.1161/JAHA.117.007524.
5
Pleiotropic effects of statins.
Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):554-62. doi: 10.4103/2230-8210.163106.
6
Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells.
Inflamm Res. 2014 Apr;63(4):267-76. doi: 10.1007/s00011-013-0695-z. Epub 2013 Dec 8.
7
Effect of atorvastatin in patients with chronic heart failure - insights from randomized clinical trials.
Arch Med Sci. 2010 Dec;6(6):866-73. doi: 10.5114/aoms.2010.19293. Epub 2010 Dec 29.
本文引用的文献
1
Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
J Thromb Haemost. 2007 Dec;5(12):2537-46. doi: 10.1111/j.1538-7836.2007.02787.x. Epub 2007 Oct 8.
2
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.
J Am Coll Cardiol. 2007 Aug 7;50(6):551-7. doi: 10.1016/j.jacc.2007.04.050. Epub 2007 Jul 23.
3
Do statins have an antiarrhythmic activity?
Cardiovasc Res. 2007 Jul 1;75(1):10-20. doi: 10.1016/j.cardiores.2007.02.029. Epub 2007 Mar 2.
4
Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.
Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1471-7. doi: 10.1161/ATVBAHA.106.128793. Epub 2007 Mar 22.
5
Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
Biochem Pharmacol. 2007 May 1;73(9):1367-75. doi: 10.1016/j.bcp.2007.01.013. Epub 2007 Jan 10.
6
Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors.
Int J Clin Pract. 2006 Aug;60(8):993-1002. doi: 10.1111/j.1742-1241.2006.01063.x.
7
Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
Eur J Heart Fail. 2007 Feb;9(2):124-8. doi: 10.1016/j.ejheart.2006.05.009. Epub 2006 Jul 21.
8
Low-dose simvastatin improves survival and ventricular function via eNOS in congestive heart failure.
Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2743-51. doi: 10.1152/ajpheart.00347.2006. Epub 2006 Jul 14.
9
Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.
J Cardiovasc Pharmacol. 2006 Jun;47(6):770-9. doi: 10.1097/01.fjc.0000211791.22411.0d.
10
Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.
Heart. 2007 Aug;93(8):903-7. doi: 10.1136/hrt.2005.068270. Epub 2006 May 2.
Zotero 插件